How have PPH shares performed in 2024?

VanEck Pharmaceutical ETF's stock was trading at $81.37 at the start of the year. Since then, PPH stock has increased by 4.3% and is now trading at $84.87. View the best growth stocks for 2024 here .

Are investors shorting VanEck Pharmaceutical ETF?

VanEck Pharmaceutical ETF saw a decrease in short interest in March. As of March 31st, there was short interest totaling 8,700 shares, a decrease of 99.4% from the March 15th total of 1,570,000 shares. Based on an average trading volume of 128,200 shares, the days-to-cover ratio is presently 0.1 days. View VanEck Pharmaceutical ETF's Short Interest .

How often does VanEck Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Pharmaceutical ETF?

VanEck Pharmaceutical ETF declared a dividend on Thursday, March 28th. Investors of record on Tuesday, April 2nd will be paid a dividend of $0.5328 per share on Friday, April 5th. The ex-dividend date is Monday, April 1st. Read our dividend analysis for PPH .

What does PPH invest in?

VanEck Pharmaceutical ETF is a equity fund issued by Van Eck. PPH focuses on health care investments and follows the Market Vectors US Listed Pharmaceutical 25 Index. The fund's investments total to approximately $497.30 million assets under management.

What stocks does VanEck Pharmaceutical ETF hold?

PPH invests in 26 holdings. Some of the stocks in their portfolio include Teva Pharmaceutical Industries (TEVA) , AbbVie (ABBV) , Johnson & Johnson (JNJ) , Eli Lilly and Company (LLY) , McKesson (MCK) , Sanofi (SNY) , Novo Nordisk A/S (NVO) , Zoetis (ZTS) , Merck & Co., Inc. (MRK) .

What is the management fee for VanEck Pharmaceutical ETF?

VanEck Pharmaceutical ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for PPH is 0.35%.

What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO?

38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com . Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of VanEck Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Bank of America (BAC) , Alibaba Group (BABA) , AeroVironment (AVAV) , Activision Blizzard (ATVI) , ARK Innovation ETF (ARKK) , Applied Materials (AMAT) , Applied Graphene Materials (AGM) , Air Canada (AC) and Abbott Laboratories (ABT) .

Who are VanEck Pharmaceutical ETF's major shareholders?

VanEck Pharmaceutical ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Aspiriant LLC (0.10%) and Summit Financial Group Inc. (0.07%).

How do I buy shares of VanEck Pharmaceutical ETF?

Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PPH

VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

→ I’m officially sounding the alarm. (From Altimetry) (Ad)

Free PPH Stock Alerts

$85.12

+0.25 (+0.29%)

(As of 09:46 AM ET)

Compare

Today's Range: $84.87
▼
$85.12
50-Day Range: $84.87
▼
$90.89
52-Week Range: $74.05
▼
$91.16

Volume: 4,855 shs
Average Volume: 123,443 shs
Market Capitalization: $514.12 million

Assets Under Management: $486.96 million
Dividend Yield: 1.83%
Net Expense Ratio: 0.35%

Get VanEck Pharmaceutical ETF alerts:

About VanEck Pharmaceutical ETF (NASDAQ:PPH)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

PPH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PPH ETF News Headlines

April 18, 2024 | theglobeandmail.com

Canada’s updated guidance on ESG-related investment fund disclosure

April 3, 2024 | msn.com

VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

April 1, 2024 | msn.com

VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328

March 7, 2024 | investorplace.com

The Top 3 ETFs to Buy in March 2024

February 28, 2024 | markets.businessinsider.com

11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields

February 28, 2024 | stocknews.com

Navigate to Success With These 4 Pharma Stocks to Buy

February 26, 2024 | investorplace.com

The 3 Hottest Healthcare ETFs to Buy in 2024

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 21, 2024 | seekingalpha.com

PPH VanEck Pharmaceutical ETF

See More Headlines

Receive PPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: Van Eck
Fund Name: VanEck Pharmaceutical ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NASDAQ
Current Symbol: NASDAQ:PPH
Inception Date: 12/20/2011
Fund Manager: Hao-Hung Peter Liao, Guo Hua Jason Jin
Web: N/A
Phone: 14089961010

Fund Focus

Asset Class: Equity
Benchmark: Market Vectors US Listed Pharmaceutical 25 Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: Global
Number of Holdings: 26

Fund Statistics

Assets Under Management: $497.30 million
Average Daily Volume: $118,360.80
Discount/Premium: 0.01%

Administrator, Advisor and Custodian

Administrator: Van Eck Associates Corporation
Advisor: Van Eck Associates Corporation
Custodian: State Street Bank and Trust Company
Distributor: Van Eck Securities Corporation
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: IMC

Options

Optionable: Optionable
Options Volume: 11
Put Options: 4
Call Options: 7
Short Interest: 1,580,000 shs

Miscellaneous

Outstanding Shares: 6,040,000
Beta: 0.72
Creation Unit: 50,000
Creation Fee: $500.00

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

VanEck Pharmaceutical ETF Expenses

Type	PPH	Health Care ETFs	Equity ETFs	NASDAQ ETFs	All ETFs
Management Fee	0.35%	0.56%	0.54%	0.48%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.34%	0.58%
Total Expense	0.35%	0.72%	0.70%	0.58%	0.70%
Fee Waiver	0.00%	-0.53%	-0.55%	-0.22%	-0.57%
Net Expense	0.35%	0.60%	0.60%	0.54%	0.58%

VanEck Pharmaceutical ETF (PPH) Holdings & Exposure

Top 10 PPH Holdings

Teva Pharmaceutical Industries(NYSE:TEVA)
Holding Weight: 5.34%
AbbVie(NYSE:ABBV)
Holding Weight: 5.21%
Johnson & Johnson(NYSE:JNJ)
Holding Weight: 5.14%
Novartis AG ADR
Holding Weight: 4.95%
Eli Lilly and Company(NYSE:LLY)
Holding Weight: 4.92%
McKesson(NYSE:MCK)
Holding Weight: 4.86%
Sanofi(NASDAQ:SNY)
Holding Weight: 4.79%
Novo Nordisk A/S(NYSE:NVO)
Holding Weight: 4.78%
Zoetis(NYSE:ZTS)
Holding Weight: 4.76%
AmerisourceBergen Corporation
Holding Weight: 4.74%

PPH Sector Exposure

PPH Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

PPH ETF - Frequently Asked Questions

How have PPH shares performed in 2024?: VanEck Pharmaceutical ETF's stock was trading at $81.37 at the start of the year. Since then, PPH stock has increased by 4.3% and is now trading at $84.87.
View the best growth stocks for 2024 here.
Are investors shorting VanEck Pharmaceutical ETF?: VanEck Pharmaceutical ETF saw a decrease in short interest in March. As of March 31st, there was short interest totaling 8,700 shares, a decrease of 99.4% from the March 15th total of 1,570,000 shares. Based on an average trading volume of 128,200 shares, the days-to-cover ratio is presently 0.1 days.
View VanEck Pharmaceutical ETF's Short Interest.
How often does VanEck Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Pharmaceutical ETF?: VanEck Pharmaceutical ETF declared a dividend on Thursday, March 28th. Investors of record on Tuesday, April 2nd will be paid a dividend of $0.5328 per share on Friday, April 5th. The ex-dividend date is Monday, April 1st.
Read our dividend analysis for PPH.
What does PPH invest in?: VanEck Pharmaceutical ETF is a equity fund issued by Van Eck. PPH focuses on health care investments and follows the Market Vectors US Listed Pharmaceutical 25 Index. The fund's investments total to approximately $497.30 million assets under management.
What stocks does VanEck Pharmaceutical ETF hold?: PPH invests in 26 holdings. Some of the stocks in their portfolio include Teva Pharmaceutical Industries (TEVA), AbbVie (ABBV), Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), McKesson (MCK), Sanofi (SNY), Novo Nordisk A/S (NVO), Zoetis (ZTS), Merck & Co., Inc. (MRK).
What is the management fee for VanEck Pharmaceutical ETF?: VanEck Pharmaceutical ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for PPH is 0.35%.

What is Bruce Gordon's approval rating as VanEck Pharmaceutical ETF's CEO?: 38 employees have rated VanEck Pharmaceutical ETF Chief Executive Officer Bruce Gordon on Glassdoor.com. Bruce Gordon has an approval rating of 98% among the company's employees. This puts Bruce Gordon in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of VanEck Pharmaceutical ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Pharmaceutical ETF investors own include Bank of America (BAC), Alibaba Group (BABA), AeroVironment (AVAV), Activision Blizzard (ATVI), ARK Innovation ETF (ARKK), Applied Materials (AMAT), Applied Graphene Materials (AGM), Air Canada (AC) and Abbott Laboratories (ABT).
Who are VanEck Pharmaceutical ETF's major shareholders?: VanEck Pharmaceutical ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Aspiriant LLC (0.10%) and Summit Financial Group Inc. (0.07%).
How do I buy shares of VanEck Pharmaceutical ETF?: Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

About VanEck Pharmaceutical ETF (NASDAQ:PPH)

PPH Stock Price History

PPH ETF News Headlines

Fund Details

Fund Focus

Fund Statistics

Administrator, Advisor and Custodian

Options

Miscellaneous

VanEck Pharmaceutical ETF Expenses

VanEck Pharmaceutical ETF (PPH) Holdings & Exposure

Top 10 PPH Holdings

PPH Sector Exposure

PPH Industry Exposure

Similar ETFs

Institutional Ownership

PPH ETF - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info